Learn insights from Madrigal Pharmaceuticals' Q2 2025 earnings: Rezdiffra's growth, new patent till 2045, global expansion, and pipeline advances.

Ghislaine Maxwell is opposing a DOJ bid to unseal grand jury transcripts from her case, arguing it would harm her ongoing ...

Jeffrey Epstein’s ex-girlfriend wants to keep grand jury records secret in the sex trafficking case that sent her to prison.

Convicted sex trafficker Ghislaine Maxwell wants the transcripts of testimony heard by the grand jury that indicted her to ...

It comes as prosecutors in the US urge a court to release some of the records in the sex trafficking case that sent her to ...

Madrigal Pharmaceuticals (MDGL) stock gains as the company's Q2 2025 results exceed expectations with a 15-fold surge in ...

The disgraced financier’s former companion said disclosure would harm her legal rights. “Jeffrey Epstein is dead,” her lawyers wrote. “Ghislaine Maxwell is not.” ...

Madrigal (MDGL) came out with a quarterly loss of $1.9 per share versus the Zacks Consensus Estimate of a loss of $3.48. This compares to a loss of $7.1 per share a year ago. These figures are ...

WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Tuesday reported a loss of $42.3 million in its second quarter. The West Conshohocken, ...

Hong Kong-based CSPC will receive $120 million from Madrigal under the deal. Elsewhere, Apellis and PTC Therapeutics won FDA ...

U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...